共查询到20条相似文献,搜索用时 125 毫秒
1.
目的研究大黄素对大鼠肝移植后CD4+CD25+调节性T细胞的比例以及对其免疫抑制功能的影响。方法双袖套法建立大鼠原位肝移植模型,以大黄素和环孢素A(CsA)分别在术后腹腔给药,并以给予PBS作为模型对照组,观察不同药物移植后大鼠存活时间的影响,以及对移植术后大鼠外周血中CD4+CD25+调节性T细胞(Tregulatory cells,Treg)亚群的变化以及免疫功能的影响。结果大黄素能显著延长大鼠原位肝移植的术后成活时间,大黄素组大鼠的平均存活时间(17.4±2.5)d与肝移植模型对照组(8.8±1.9)d相比差异具有统计学意义;大鼠肝移植后大黄素给药可显著上调受体大鼠外周血以及肝内CD4+CD25+Treg的比例,并显著增强CD4+CD25+Treg抑制效应性T细胞的增殖能力(P0.05)。结论大黄素能够延长大鼠原位肝移植的术后成活时间,并可能通过上调外周血以及肝内CD4+CD25+Treg的数量及免疫抑制功能来实现移植后免疫排斥反应的抑制。 相似文献
2.
大鼠肝移植术后输注ω-3多不饱和脂肪酸对T淋巴细胞的影响 总被引:1,自引:0,他引:1
目的 探讨大鼠肝移植术后应用ω-3多不饱和脂肪酸对移植肝脏功能、受体T淋巴细胞和急性排斥反应的影响.方法 行BN(RTln)大鼠到Lewis(RT11)二袖套法大鼠肝移植18例,术后颈内静脉插管,微量泵匀速输注液体.生理盐水NS组(n=6)输注生理盐水,肠外营养PN组(n=6)输注营养液,脂肪酸OM组(n=6)输注营养液+ω-3脂肪乳.术后第7天处死大鼠,留取肝组织标本病理检查,取血清检测生化指标.取抗凝血0.5 ml,流式细胞仪检测CD4+、CD8+、CD4+CD25+T细胞和CD8+CD28-T细胞.结果 大鼠肝移植术后输注ω-3脂肪酸的OM组CD4+、CD8+、CD4+CD25+和CD8+CD28-T细胞下降,与Ns组比较差异有统计学意义(t=4.28,P<0.01;t=2.63,P<0.05;t=2.59,P<0.05;t=8.86,P<0.01).OM组CD4+、CD8+、CD4+CD25+和CD8+CD28-T细胞下降,与PN组比较差异有统计学意义(分别t=8.06,t=3.57,t=5.35.t=7.98,均P<0.01).OM组CD4+/CD8+比值下降,与NS组和PN组比较差异有统计学意义(分别t=2.41,t=8.74,均P<0.01).病理学检查移植肝排斥反应强度(rejection activity index,RAI)评分,NS组为7.17±0.98,PN组为6.17±0.75,OM组为4.33±0.52,OM组与NS组、PN组比较排斥反应减轻(分别t=6.25,t=4.92,均P<0.01).结论 静脉输注ω-3多不饱和脂肪酸可以抑制T淋巴细胞,显著降低CD4+辅助性T细胞比例,减轻排斥反应.抑制性T细胞和调节性T细胞与ω-3脂肪酸减轻大鼠肝移植排斥反应的效应无关. 相似文献
3.
目的研究大鼠肝移植后自发免疫耐受的形成与移植肝内CD4~ CD25~ 调节性T细胞(Tr细胞)的关系。方法按供、受者不同将实验分为3组。急性排斥组:DA大鼠为供者,LEW大鼠为受者;自发耐受组:LEW大鼠为供者,DA大鼠为受者;同基因组:供、受者均为DA大鼠。各组均建立大鼠原位肝移植模型。分别在肝移植术后4、7、14、30和90 d时采用密度梯度离心法分离移植肝内淋巴细胞,免疫磁珠分离(MACS)法分选出CD4~ CD25~ Tr细胞;用流式细胞术(FCM)检测细胞纯度,同时分析CD4~ CD25~ Tr细胞比例的变化;体外细胞增殖试验研究CD4~ CD25~ Tr细胞对CD4~ CD25~-T细胞的免疫抑制作用。结果肝移植早期,急性排斥组和自发耐受组移植肝内CD4~ CD25~ Tr细胞比例均明显增加,其中急性排斥组增加更为明显;移植后4 d左右,两组CD4~ CD25~ Tr细胞比例开始下降,急性排斥组的下降幅度较大;移植后30 d,自发耐受组受者的移植肝内CD4~ CD25~ Tr细胞比例达到第2次高峰,约在移植后90 d时下降至正常生理水平。移植后7 d左右,急性排斥组受者均因发生排斥反应而死亡,而自发耐受组受者均存活。此外,CD4~ CD25~ Tr细胞能有效抑制CD4~ CD25~-T细胞的增殖。结论CD4~ CD25~ Tr细胞是一种具有特异免疫调节功能的T细胞亚群,其主动的免疫抑制功能可能是诱导大鼠肝移植自发免疫耐受的机制之一。 相似文献
4.
目的 探讨全身照射(TBI)预处理诱导大鼠肝移植术后急性排斥反应的发生机制,及CD4~+ CD25~+调节性T细胞的变化在诱导免疫耐受中的作用.方法 以雄性Lewis、DA大鼠为供、受体,随机分为正常对照组、同种肝移植组、自发免疫耐受组、急性排斥反应组.观察各组受体的生存时间及生存率,检测受体术后外周血中ALT、TB含量、Foxp3~+ CD4~+ CD25~+ 调节性T细胞和T细胞亚群上GITR的表达,检测受体术后第14天移植肝的病理变化和受体脾脏CTL杀伤活性.结果 自发免疫耐受组,术后经历短暂排斥反应最终获得免疫耐受并长期存活.急性排斥反应组,在术后第17~21天死亡,与其他组相比,外周血血清中ALT、TB含量明显升高,而Foxp3~+ CD4~+ CD25~+调节性T细胞比例明显降低.TBI预处理大鼠供肝致受体外周血中CD3~+ CD4~+ T细胞上GITR表达降低,CD3~+CD8~+T细胞上GITR表达增加,提高CTL的杀伤活性.结论 通过TBI清除供体大鼠肝移植物中携带的旁路淋巴细胞,致受体外周血中Foxp3~+ CD4~+ CD25~+调节性T细胞表达降低,而使CD3~+ CD8~+T细胞上GITR表达增加,共同诱导大鼠肝移植术后急性排斥反应发生和耐受障碍. 相似文献
5.
6.
目的 评价具有免疫抑制作用的CD8+CD28-调节性T淋巴细胞(Treg)体内输注在抑制大鼠肝移植急性排斥反应中的作用.方法 建立近交系大鼠肝移植自发耐受及急性排斥反应模型.从肝移植自发耐受模型受者脾脏中分离CD8+CD28-Treg,于急性排斥反应模型建立前1 d输注给受者,比较不同的输注组间受者的存活时间和移植肝病理学表现.结果 来自自发耐受模型(LEW大鼠为供者,DA大鼠为受者)的CD8+CD28-Treg输注可以延长急性排斥反应模型(LEW大鼠为供者,BN大鼠为受者)受者的存活时间,由(14.0±2.2)d延长至(24.0±3.0)d(P<0.01),移植肝病理学显示排斥反应程度减轻.结论 大鼠肝移植自发耐受模型受者体内诱导的CD8+CD28-Treg具有抑制急性排斥反应的作用,该免疫抑制作用具有抗原特异性. 相似文献
7.
目的 探讨肝癌肝移植病人移植前后外周血和肿瘤组织中CD4+CD25+FOXP3+T细胞比例变化及其临床意义.方法 用流式细胞仪检测肝癌肝移植病人和其他肝移植病人术后外周血中CD4+CD25+FOXP3+T细胞的比例,并采用正常人作对照.用免疫组化法检测肝癌病人和非肝癌病人肿瘤组织中FoxP3的表达及CD8+T细胞浸润的比例.观察肝癌肝移植病人术后及肿瘤复发后调节性T细胞的变化及其对肿瘤复发的影响.结果 流式细胞检测显示肝癌肝移植、非肝癌肝移植的病人术后外周血中CD4+CD25+FOXP3+T细胞占CD4+T细胞的比例较正常人明显升高,分别为(10.15±1.00)%、(5.30±1.64)%和(3.20±1.18)%,P<0.05.肝癌肝移植肿瘤复发病人较未复发病人外周血CD4+CD25+FOXP3+T比例明显升高,分别为(15.15±1.50)%和(6.80±1.50)%,P<0.01.免疫组化检测显示肿瘤组织中FOXP3+T细胞增多,CD8+T细胞浸润明显减少.结论 肝癌肝移植肿瘤复发的病人外周血中CD4+CD25+FOXP3+T细胞比例升高.调节性T细胞可能通过减少CD8+T细胞浸润,加速肿瘤复发. 相似文献
8.
CD4+ CD25+ Tr细胞与大鼠肝移植自发免疫耐受关系的研究 总被引:1,自引:0,他引:1
目的研究CD4^+CD25^+Tr细胞及其相关基因Foxp3与大鼠肝移植自发免疫耐受的关系。方法双袖套法建立大鼠原位肝移植模型;密度梯度离心法分离肝内淋巴细胞;免疫磁性分离法(MACS)分选CD4^+CD25^+Tr细胞,流式细胞术(FCM)检测所得细胞纯度。体外细胞增殖试验研究CD4^+CD25^+Tr细胞的免疫抑制作用。Western蛋白印迹法检测CD4^+CD25^+Tr细胞Scurfin蛋白表达。结果自发耐受组大鼠移植肝内CD4^+CD25^+Tr细胞含量显著高于急性排斥组。混合淋巴细胞反应中,LEW大鼠的脾细胞比DA大鼠自身的脾细胞更能刺激CD4^+CD25^+T细胞的增殖。CD4^+CD25^-T细胞能抑制CD4^+CD25^-T细胞的增殖,当加入外源性IL-2(200U/ml)时,该抑制作用被逆转。结论转录因子Foxp3介导的CD4^+CD25^+Tr细胞的免疫抑制作用可能是诱导大鼠肝脏移植自发免疫耐受的机制之一。 相似文献
9.
目的 探讨骨髓输注联合阻断共刺激通路对大鼠移植皮肤存活的影响及可能机制.方法 以Lewis大鼠为受者,皮肤移植前经尾静脉输注供者(BN大鼠)骨髓细胞2×108 个,并于骨髓输注当天、输注后第2、4、6及8天腹腔注射抗CD25单克隆抗体,同时按照分组要求腹腔注射细胞毒性T淋巴细胞相关抗原4融合蛋白(CTLA4Ig组)、抗CD154单克隆抗体(抗CD154单抗组)以及CTLA4Ig和抗CD154单克隆抗体(联合处理组),于骨髓输注后第8天移植BN大鼠的皮肤.另以仅行皮肤移植者为对照(对照组).观察各组移植物抗宿主病(GVHD)的发生情况、外周血中供者细胞嵌合率、T淋巴细胞凋亡率及移植皮肤的存活时间.结果 各组均未观察到GVHD的发生.骨髓输注后第7天即可在CTLA4Ig组、抗CD154单抗组及联合处理组观察到嵌合现象,至第21天时,嵌合率仍维持于一定水平,联合处理组明显高于其它三组(P<0.01).骨髓输注后第7及21天,CTLA4Ig组、抗CD154单抗组及联合处理组间两两比较,T淋巴细胞凋亡率的差异无统计学意义,但均显著高于对照组(P<0.05,P<0.01).CTLA4Ig组、抗CD154单抗组及联合处理组移植皮肤的存活时间显著长于对照组(P<0.01),联合处理组移植皮肤存活时间为(16.7±3.1)d,明显长于CTLA4Ig组和抗CD154单抗组(P<0.05).结论 骨髓输注联合阻断共刺激通路能够延长移植皮肤存活时间,其机理可能与诱导嵌合和T淋巴细胞凋亡有关. 相似文献
10.
目的研究供体骨髓来源的白细胞介素12 p35(IL-12p35)基因沉默的树突状细胞(IL-12 p35 silenced DC)联合大鼠CD40L单克隆抗体(CD40L mAb)对大鼠小肠移植免疫耐受的诱导。方法实验动物随机分为3组,每组8对,分别于手术前7天进行不同预处理后进行小肠移植。A组:受体注射生理盐水;B组:受体注射供体IL-12 p35 silenced DC,C组:受体静脉注射供体IL-12 p35 silenced DC,同时腹腔注射CD40L mAb。观察受体存活时间,移植小肠采用病理学检察及细胞凋亡检测,受体血清检测IL-2、干扰素(INF)-γ水平。结果C组受体动物存活时间为(23.3±6.0)d,显著长于A、B两组[(6.5±1.5)d,(15.1±4.9)d];C组移植小肠炎性细胞浸润、黏膜结构破坏程度和肠黏膜细胞的凋亡数目明显低于A、B组[(9.5±5.6)比(23.8±6.2)、(18.7±6.3),(P<0.01)];C组受体大鼠血清IL-2浓度为(185.8±18.2)ng/L,显著低于A、B两组[(294.1±15.6)ng/L、(225.8±14.5)ng/L,(P<0.01、P<0.05)];C组受体大鼠血清INF-γ浓度为(75.6±8.6)ng/L,显著低于A、B两组[(110.5±12.4)ng/L、(89.1±9.2)ng/L,(P<0.01、P<0.05)]。结论术前输注供体来源的IL-12 p35 silenced DC联合CD40L mAb,可在一定程度上抑制小肠移植的排斥反应,诱导受体产生免疫耐受。 相似文献
11.
Human CD4+ CD25+ T cells regulate CD8+ T-cell activation 总被引:2,自引:0,他引:2
Câmara NO Ng WF Hernandes-Fuentes M Eren E Lechler RI 《Transplantation proceedings》2002,34(7):2858-2860
12.
13.
14.
Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery 总被引:11,自引:0,他引:11
BACKGROUND: Rapamycin (Rapa) is an immunosuppressant that is used in patients and animal models to control allograft rejection. Its mechanisms of action are not fully understood. In this article, the authors have investigated the effects of therapeutic doses of Rapa on both thymic and peripheral T-cell populations in the adult rat. METHODS: The therapeutic dosage of Rapa was optimized using cardiac transplantation between LEW and DA rats. Thymic morphology was assessed by hematoxylin-eosin staining. Flow cytometric analysis was performed to analyze T-cell phenotype and apoptosis. T-cell receptor (TCR)-mediated T-cell responsiveness was evaluated by 3[H]-thymidine deoxyribose incorporation. RESULTS: Rapa induced atrophy in the thymus but not in peripheral lymphoid organs. Moreover, fibrosis occurred in thymus that was long-lasting after Rapa withdrawal. In animals treated with Rapa, there was a significant reduction in CD4+CD8+ thymocytes caused by accelerated apoptosis, whereas CD4-CD8-, CD4+CD8-, and CD8+CD4- populations remained unaffected. In contrast, the cellularity of the periphery lymphoid organs was not altered. Within the CD4+ thymocyte population, CD4+CD25+ thymocytes were resistant to Rapa-accelerated apoptosis, and in the periphery, the ratio of CD4+CD25+ to CD4+CD25- T cells was increased. Notably, the peripheral CD4+CD25+ T cells were hyporesponsive to TCR-mediated activation. CONCLUSIONS: The resistance of the peripheral CD4+CD25+ T cells to Rapa treatment might contribute to its immunosuppressive action. The long-term effects of Rapa on thymus atrophy and thymocyte development requires consideration with respect to its clinical application. 相似文献
15.
Yuling H Ruijing X Xiang J Yanping J Lang C Li L Dingping Y Xinti T Jingyi L Zhiqing T Yongyi B Bing X Xinxing W Youxin J Fox DA Lundy SK Guohua D Jinquan T 《Journal of the American Society of Nephrology : JASN》2008,19(11):2130-2139
The source of IgA and the mechanism for deposition of IgA in the mesangium remain unknown for primary IgA nephropathy. Because CD19(+)CD5(+) B cells are important producers of IgA and contribute to several autoimmune diseases, they may play an important role in IgA nephropathy. In this study, flow cytometry, quantitative PCR, and confocal microscopy were used to assess the frequency, distribution, Ig production, CD phenotypes, cytokine production, and sensitivity to apoptosis of CD19(+)CD5(+) B cells in the peripheral blood, peritoneal fluid, and kidney biopsies of 36 patients with primary IgA nephropathy. All patients with IgA nephropathy were significantly more likely to have CD19(+)CD5(+) B cells in the peripheral blood, peritoneal fluid, and kidney biopsies than were five control subjects and 10 patients with active systemic lupus erythematosus. The 33 patients who had IgA nephropathy and responded to treatment demonstrated a significant decrease in CD19(+)CD5(+) B cells in the peripheral blood, peritoneal fluid, and kidney (all P < 0.01). In the three patients who had IgA nephropathy and did not respond to treatment, the frequency of CD19(+)CD5(+) B cells did not change. CD19(+)CD5(+) B cells isolated from patients with untreated IgA nephropathy expressed higher levels of IgA, produced more IFN-gamma, and were more resistant to CD95L-induced apoptosis than cells isolated from control subjects and patients with lupus; these properties reversed with effective treatment of IgA nephropathy. In conclusion, these results strongly suggest that CD19(+)CD5(+) B cells play a prominent role in the pathogenesis of primary IgA nephropathy. 相似文献
16.
BACKGROUND: Injection of neonatal BALB/c mice with semi-allogeneic splenocytes leads to antigen-specific tolerance lasting into adulthood. Tolerant mice accept A/J skin grafts and fail to generate CD8 cytotoxic T lymphocyte (CTL) activity against A/J targets. Anergic CD8 T cells are present in tolerant mice, and CD4 regulatory cells function to maintain CD8 cell anergy. METHODS: Neonatal BALB/c mice were injected with 108 live CAF, splenocytes, and mice were deemed tolerant by accepting A/J grafts over 40 days. CD8 cell proliferation was measured by in vitro incorporation of bromodeoxyuridine coupled with fluorescence-activated cell sorter analysis. Alloantigen-specific cytotoxicity was tested using 51Cr release assays of A/J or third-party targets. RESULTS: We demonstrate that A/J-specific anergic CD8 cells are present in neonatal primed mice that develop tolerance but not in neonatal primed mice that reject A/J skin grafts. Anergic CD8 cells show decreased proliferation and no CTL activity against A/J targets. Addition of interleukin-2 (IL-2) to unfractionated cultures fails to restore CTL activity against A/J targets. However, addition of IL-2 to CD4-depleted cultures restores A/J-specific CD8 CTL activity. Removal of CD4+/CD25+ cells, but not CD4+/CD25- cells, also restores CD8 CTL activity against A/J in the presence, but not the absence, of IL-2. Moreover, when added back into cultures, purified CD4+/CD25+ cells from tolerant mice inhibit the generation of CD8 CTL against A/J targets. CONCLUSION: These data indicate that CD8 anergy is associated with the state of tolerance, and that CD4+CD25+ cells from tolerant mice function to maintain A/J-specific CD8 cell anergy in vitro. 相似文献
17.
目的探讨CD3、CD57、CD20细胞在原发性肝细胞癌(HCC)、癌旁、肝硬化及正常肝组织中的数量及意义.方法HCC 60例,单纯性肝硬化62例,正常肝组织23例,以免疫组化SP法进行CD3、CD57、CD20染色,对阳性细胞数进行定量分析并与临床资料进行相关探讨.结果(1)各组CD3+细胞平均数从高到低为癌旁组织、癌组织、肝硬化组织、正常肝组织(P<0.05);各组CD57+细胞平均数从高到低为癌组织、癌旁组织、正常肝组织、肝硬化组织(P <0.05);各组CD20+细胞平均数从高到低为癌组织、癌旁组织、肝硬化组织、正常肝组织(P <0.01).(2)HCC中CD3+细胞、CD57+细胞、CD20+细胞与组织学分级均无明显关系.(3)HCC中CD57+细胞和CD20+细胞随着临床分期的发展有下降的趋势(P <0.05);HCC中CD3+细胞平均数与临床TNM分期无关.(4)HCC中15月内有转移组的CD57+、CD3+细胞数均少于无转移组(P<0.01).HCC患者15月内有无转移与HCC和癌旁组织中的B细胞分布均无关.结论临床上,随着HCC患者的病情恶化,CD3+、CD57+、CD20+细胞逐渐减少.CD3+、CD57+、CD20+细胞可成为反映机体抗肿瘤特异性细胞免疫状态和生物学行为及判断患者预后的重要指标. 相似文献
18.
19.
目的:探讨血清微环境对小鼠T细胞衰老的调节作用。方法:分别取年老(12~14月龄)及年轻(1.5~2月龄)小鼠各10只,提取其脾脏淋巴细胞及血清,实验分4组。组I为年老鼠T淋巴细胞+10%年轻鼠血清;组II为年老鼠T淋巴细胞+10%年老鼠血清;组III为年轻鼠T淋巴细胞+10%年轻鼠血清;组IV为年轻鼠T淋巴细胞+10%年老鼠血清。培养48h后,经流式细胞术研究CD8+CD28+共表达率差异。结果:组I和组II T细胞表面的CD8+CD28+共表达率分别是(10.84±0.6841)%和(3.18±0.1789)%,组III和组IV T细胞表面的CD8+CD28+共表达分别是(12.5±0.9445)%和(8.36±0.2074)%。各组间对比有统计学差异(P〈0.05)结论:血清微环境具有调节小鼠T细胞衰老的作用,年轻鼠血清能使年老鼠的T细胞表面的CD8+CD28+共表达率提高,年老鼠的血清能使年轻鼠的T细胞表面的CD8+CD28+共表达率降低。 相似文献
20.
Oluwole SF Oluwole OO DePaz HA Adeyeri AO Witkowski P Hardy MA 《Transplant immunology》2003,11(3-4):287-293
The Holy Grail of clinical organ transplantation is the safe induction of allograft tolerance. Transplant tolerance has been successfully induced in animal models. Since T cells play a pivotal role in graft rejection, modulating T cell function has been the primary focus of studies aimed at inducing transplant tolerance. Rodent models of transplant tolerance induction include central deletion and peripheral mechanisms involving activation-induced cell death (AICD), anergy, immune deviation, and production of regulatory T cells. These mechanisms are not mutually exclusive. Although clonal deletion and anergy limit self-reactive T cells in the thymus, these mechanisms alone are not sufficient for controlling self-reactive T cells in the periphery. There is now evidence that the adult animal harbors two functionally distinct populations of CD4(+) T cells; one mediates autoimmune disease and the other dominantly inhibits it. The latter cells express CD4, CD25 and CTLA-4. These thymus-derived T cells have recently been shown to mediate the induction and maintenance of transplant tolerance. These CD4(+)CD25(+) T cells are similar in origin, phenotype, and function to those that maintain natural self-tolerance and T cell homeostasis in the periphery. Against this background, is it possible that alloantigen specific regulatory T cells might be generated and expanded ex vivo before organ transplantation and then infused to induce long-term tolerance, perhaps without the need for chronic immunosuppression? 相似文献